Notice Pursuant to the National Cooperative Research and Production Act of 1993-Healthcare Standards Institute Foundation

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

March 27, 2023

Issuing agencies

Justice DepartmentAntitrust Division

Full Text

<html>
<head>
<title>Federal Register, Volume 88 Issue 58 (Monday, March 27, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 58 (Monday, March 27, 2023)]
[Notices]
[Page 18182]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-06190]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Healthcare Standards Institute Foundation

    Notice is hereby given that, on January 6, 2023, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Healthcare Standards 
Institute Foundation (``HSI Foundation'') has filed written 
notifications simultaneously with the Attorney General and the Federal 
Trade Commission disclosing (1) the name and principal place of 
business of the standards development organization and (2) the nature 
and scope of its standards development activities. The notifications 
were filed for the purpose of invoking the Act's provisions limiting 
the recovery of antitrust plaintiffs to actual damages under specified 
circumstances.
    Pursuant to Section 6(b) of the Act, the name and principal place 
of business of the standards development organization is: Healthcare 
Standards Institute Foundation, Grapevine, TX. The nature and scope of 
HSI Foundation's standards development activities are: the creation of 
a healthcare quality management system standard that clearly and 
specifically addresses patient safety, quality of care, accessibility, 
affordability and equity.

Suzanne Morris,
Deputy Director, Civil Enforcement Operations, Antitrust Division.
[FR Doc. 2023-06190 Filed 3-24-23; 8:45 am]
BILLING CODE 4410-11-P


</pre></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on March 27, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.